These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 25414120)

  • 21. Recent advances in understanding inflammation and remodeling in the airways in chronic obstructive pulmonary disease.
    Sohal SS; Ward C; Danial W; Wood-Baker R; Walters EH
    Expert Rev Respir Med; 2013 Jun; 7(3):275-88. PubMed ID: 23734649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Muscarinic Receptor Antagonists.
    Matera MG; Cazzola M
    Handb Exp Pharmacol; 2017; 237():41-62. PubMed ID: 27787709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Research and development of bronchodilators for asthma and COPD with a focus on G protein/KCa channel linkage and β2-adrenergic intrinsic efficacy.
    Kume H; Fukunaga K; Oguma T
    Pharmacol Ther; 2015 Dec; 156():75-89. PubMed ID: 26432616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycopyrronium bromide for the treatment of chronic obstructive pulmonary disease.
    Riario-Sforza GG; Ridolo E; Riario-Sforza E; Incorvaia C
    Expert Rev Respir Med; 2015 Feb; 9(1):23-33. PubMed ID: 25547422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical potential of aclidinium bromide in chronic obstructive pulmonary disease.
    Jones PW
    Int J Chron Obstruct Pulmon Dis; 2015; 10():677-87. PubMed ID: 25848244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The reasons for triple therapy in stable COPD patients in Japanese clinical practice.
    Miyazaki M; Nakamura H; Takahashi S; Chubachi S; Sasaki M; Haraguchi M; Terai H; Ishii M; Fukunaga K; Tasaka S; Soejima K; Asano K; Betsuyaku T;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1053-9. PubMed ID: 26082629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beyond TGFβ--novel ways to target airway and parenchymal fibrosis.
    Boorsma CE; Dekkers BG; van Dijk EM; Kumawat K; Richardson J; Burgess JK; John AE
    Pulm Pharmacol Ther; 2014 Dec; 29(2):166-80. PubMed ID: 25197006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of tiotropium bromide on airway remodeling in a chronic asthma model.
    Kang JY; Rhee CK; Kim JS; Park CK; Kim SJ; Lee SH; Yoon HK; Kwon SS; Kim YK; Lee SY
    Ann Allergy Asthma Immunol; 2012 Jul; 109(1):29-35. PubMed ID: 22727154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholinergic pathways in the lungs and anticholinergic therapy for chronic obstructive pulmonary disease.
    Belmonte KE
    Proc Am Thorac Soc; 2005; 2(4):297-304; discussion 311-2. PubMed ID: 16267352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What can in vitro models of COPD tell us?
    Krimmer DI; Oliver BG
    Pulm Pharmacol Ther; 2011 Oct; 24(5):471-7. PubMed ID: 21182977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Commonalities between the pro-fibrotic mechanisms in COPD and IPF.
    Murray LA
    Pulm Pharmacol Ther; 2012 Aug; 25(4):276-80. PubMed ID: 21983244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of the bronchial microvasculature in the airway remodelling in asthma and COPD.
    Zanini A; Chetta A; Imperatori AS; Spanevello A; Olivieri D
    Respir Res; 2010 Sep; 11(1):132. PubMed ID: 20920222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological interaction between LABAs and LAMAs in the airways: optimizing synergy.
    Calzetta L; Matera MG; Cazzola M
    Eur J Pharmacol; 2015 Aug; 761():168-73. PubMed ID: 25981302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Segment-dependent expression of muscarinic acetylcholine receptors and G-protein coupling in the equine respiratory tract.
    Abraham G; Kottke C; Ammer H; Dhein S; Ungemach FR
    Vet Res Commun; 2007 Feb; 31(2):207-26. PubMed ID: 17180451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Airway bacteria drive a progressive COPD-like phenotype in mice with polymeric immunoglobulin receptor deficiency.
    Richmond BW; Brucker RM; Han W; Du RH; Zhang Y; Cheng DS; Gleaves L; Abdolrasulnia R; Polosukhina D; Clark PE; Bordenstein SR; Blackwell TS; Polosukhin VV
    Nat Commun; 2016 Apr; 7():11240. PubMed ID: 27046438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long acting muscarinic antagonists for the treatment of chronic obstructive pulmonary disease: a review of current and developing drugs.
    Mastrodicasa MA; Droege CA; Mulhall AM; Ernst NE; Panos RJ; Zafar MA
    Expert Opin Investig Drugs; 2017 Feb; 26(2):161-174. PubMed ID: 28004591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-acting muscarinic antagonists for the prevention of exacerbations of chronic obstructive pulmonary disease.
    Jones PW
    Ther Adv Respir Dis; 2015 Jun; 9(3):84-96. PubMed ID: 25801643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Muscarinic receptor antagonists, from folklore to pharmacology; finding drugs that actually work in asthma and COPD.
    Moulton BC; Fryer AD
    Br J Pharmacol; 2011 May; 163(1):44-52. PubMed ID: 21198547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effect of inhaled ipratropium bromide on airway and lung tissue muscarinic receptors in a rat model of COPD].
    Yao W; Wang G; Zhu H; Zhao M
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 Feb; 22(2):95-7. PubMed ID: 11820950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bronchodilators, receptors and cross-talk: Together is better?
    Panettieri RA
    Postgrad Med; 2015; 127(7):771-80. PubMed ID: 26293997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.